Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function

Virology

Volumn 222, Issue 1, 1996, Pages 1-13

  Yates, John L ^a   Camiolo, Sarah M ^a   Ali, Sayed ^a   Ying, Angela ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

HERPES; HERPESVIRIDAE; HERPESVIRUS PAPIO; HUMAN HERPESVIRUS 4; MAMMALIA; PAPIO;

EID: 0030218080     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0392     Document Type: Article

References (57)

1. Adams, A. (1987). Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61, 1743-1746.
2. Ambinder, R. F., Mullen, M. A., Chang, Y.-N., Hayward, G. S., and Hayward, S. D. (1991). Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65, 1466-1478.
3. Bochkarev, A., Barwell, J. A., Pfuetzner, R. A., Furey, W., Edwards, A. M., and Frappier, L. (1995). Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA1. Cell 83, 39-46.
4. Brun, C., Dubey, D., and Huberman, J. A. (1995). pDblet, a stable autonomously replicating shuttle vector for Schizosaccharomyces pombe. Gene 164, 173-177.
5. Buell, G. N., Reisman, D., Kintner, C., Crouse, G., and Sugden, B. (1981). Cloning overlapping DNA fragments from the B95-8 strain of Epstein-Barr virus reveals a site of homology to the internal repetition. J. Virol. 40, 977-982.
6. Chen, M.-R., Middeldorp, J. M., and Hayward, S. D. (1993). Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67, 4875-4885.
7. Chen, M.-R., Zong, J., and Hayward, S. D. (1994). Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein. Virology 205, 486-495.
8. Chen, F., Zou, J.-Z., Renzo, L., Wingerg, G., Hu, L.-F., Klein, E., Klein, G., and Ernberg, I. (1995). A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt Lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69, 3752-3758.
9. Chittenden, T., Lupton, S., and Levine, A. J. (1989). Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication. J. Virol. 63, 3016-3025.
10. Clemens, H. L., and Carlson, J. O. (1989). Regulated expression of the feline panleukopenia virus P38 promoter on extrachromosomal FPV/ EBV chimeric plasmids. J. Virol. 63, 2737-2745.
11. Falk, L., Deinhardt, F., Nonoyama, M., Wolfe, L. G., Bergholz, C., Lapin, B., Yakovleva, L., Agrba, V., Henle, G., and Henle, W. (1976). Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus. Int. J. Cancer 18, 798-807.
12. Frost, E., and Williams, J. (1978). Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue. Virology 91, 39-50.
13. Gahn, T. A., and Schildkraut, C. L. (1989). The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58, 527-535.
14. Gahn, T. A., and Sugden, B. (1995). An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69, 2633-2636.
15. Gerber, P., Kalter, S. S., Schidlovsky, G., Petrson, W. D., and Daniel, M. D. (1977). Biologic and antigenic characteristics of Epstein-Barr virus-related herpesviruses of chimpanzees and baboons. Int. J. Cancer 20, 448-459.
16. Goldsmith, K., Bendell, L., and Frappier, L. (1993). Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 67, 3418-3426.
17. Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I., and Howard, B. H. (1982). The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci. USA 79, 6777-6781.
18. Graham, F. L., and Van der Eb, A. J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
19. Haase, S. B., Heinzel, S. S., and Calos, M. P. (1994). Transcription inhibits the replication of autonomously replicating plasmids in human cells. Mol. Cell. Biol. 14, 2516-2524.
20. Harrison, S., Fisenne, K., and Hearing, J. (1994). Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 68, 1913-1925.
21. Heller, M., and Kieff, E. (1981). Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio. J. Virol. 37, 821-826.
22. Hirt, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
23. Hsieh, C.-L. (1994). Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14, 5487-5494.
24. Kieff, E., and Liebowitz, D. (1990). Epstein-Barr Virus and its replication. In "Virology" (B. N. Fields, D. M. Knipe, et al., Eds.), pp. 1889-1920. Raven Press, New York.
25. Kiledjian, M., and Dreyfuss, G. (1992). Primary structure and binding activity of the hnRNP U protein: Binding RNA through RGG box. EMBO J. 11, 2655-2664.
26. Klein, G. (1994). Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77, 791-793.
27. Kraft, R., Tardiff, J., Krauter, K. S., and Leinwand, L. A. (1988). Using mini-prep plasmid DNA for sequencing double stranded templates with Sequenase. BioTechniques 6, 544-546.
28. Krysan, P. J., Haase, S. B., and Calos, M. P. (1989). Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol. 9, 1026-1033.
29. Lee, Y. S., Tanaka, A., Lau, R. H., Nonoyama, M., and Rabin, H. (1981). Linkage map of the fragments of herpesvirus papio DNA. J. Virol. 37, 710-720.
30. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., and Masucci, M. G. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685-658.
31. Ling, P. D., Ryon, J. J., and Hayward, S. D. (1993). EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67, 2990-3003.
32. Loeb, D., Schwab, D., Sung, N., Pesano, R. L., Sexton, C. J., Hutchison, C., and Pagano, J. S. (1990). Plasmid origin of replication of herpes virus Papio: DNA sequence and enhancer function. J. Virol. 64, 2876-2883.
33. Lupton, S., and Levine, A. J. (1985). Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus derived plasmids in human cells. Mol. Cell. Biol. 5, 2533-2542.
34. Mackey, D., Middleton, T., and Sugden, B. (1995). Multiple regions of EBNA1 can link DNAs. J. Virol. 69, 6199-6208.
35. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982). "Molecular Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
36. Middleton, T., and Sugden, B. (1992). A chimera of EBNA1 and the estrogen receptor activates transcription but not replication. J. Virol. 66, 1795-1798.
37. Middleton, T., and Sugden, B. (1994). Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol. 68, 4067-4071.
38. Miller, G. (1990). Epstein-Barr virus, biology, pathogenesis, and medical aspects. In "Virology" (B. N. Fields et al., Eds.), pp. 1921-1957. Raven Press, New York.
39. Miyashita, E. M., Yang, B., Lam, K. M., Crawford, D. H., and Thorley-Lawson, D. A. (1995). A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80, 593-601.
40. Pesano, R. L., and Pagano, J. S. (1986). Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function. J. Virol. 60, 1159-1162.
41. Polvino-Bodnar, M., and Schaffer, P. A. (1992). DNA binding activity is required for EBNA 1-dependent transcriptional activation and DNA replication. Virology 187, 591-603.
42. Qu, L., and Rowe, D. T. (1992). Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66, 3715-3721.
43. Rabin, H., Neubauer, R. H., Hopkins, R. F., Dzhikidze, E. K., Shevtsova, Z. V., and Lapin, B. A. (1977). Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease. Intervirology 8, 240-249.
44. Reisman, D., and Sugden, B. (1986). Trans-activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6, 3838-3846.
45. Reisman, D., Yates, J. L., and Sugden, B. (1985). A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5, 1822-1832.
46. Snudden, D. K., Hearing, J., Smith, P. R., Grasser, F. A., and Griffin, B. E. (1994). EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J. 13, 4840-4847.
47. Sugden, B., Marsh, K., and Yates, J. L. (1985). A Vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol. Cell. Biol. 5, 410-413.
48. Sugden, B., and Warren, N. (1989). A promoter of Epstein-Barr virus which can function during latent infection can be trans-activated by EBNA1, a viral protein required for DNA replication during latent infection. J. Virol. 63, 2644-2649.
49. Suzuki, K., Olvera, J., and Wool, I. G. (1991). Primary structure of rat ribosomal protein S2. J. Biol. Chem. 266, 20007-20010.
50. Tierney, R. J., Steven, N., Young, L. S., and Rickinson, A. B. (1994). Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68, 7374-7385.
51. Wrightham, M. N., Stewart, J. P., Nusrat, J. J., Pepper, S. D. V., Sample, C., Rooney, C. M., and Arrand, J. R. (1995). Antigenic and sequence variation in the C-terminal domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208, 521-530.
52. Wysokenski, D. A., and Yates, J. L. (1989). Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63, 2657-2666.
53. Yates, J. L. (1996). Epstein-Barr virus DNA replication. In "Eukaryotic DNA Replication" (M. DePamphilis, Ed.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, in press.
54. Yates, J. L., and Camiolo, S. M. (1988). Dissection of DNA replication and enhancer activation function of Epstein-Barr virus nuclear antigen 1. In "Cancer Cells: Eukaryotic DNA Replication" (B. Stillman and T. Kelley, Eds.), Vol. 6, pp. 197-205. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
55. Yates, J. L., and Guan, N. (1991). Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65, 483-488.
56. Yates, J. L., Warren, N., Reisman, D., and Sugden, B. (1984). A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81, 3806-3810.
57. Yates, J. L., Warren, N., and Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815.